References
- Capos L., Guyotat D., Archimbaud E., Devaux Y., Treille D., Larese A., Maupas J., Gentilhomme O., Ehrsam A., Fiere D. Surface marker expression in adult acute myeloid leukemia: Correlations with initial characteristics, morphology and response to therapy. Br. J. Haematol. 1989; 72: 161–166
- Borowitz M. J., Gockerman J. P., Moore J. O., Civin C. I., Page S. O., Robertson J., Bigner S. H. Clinicopathological and cytogenetic features of CD34 (MY10) positive acute nonlymphoblastic leukemia. Am. J. Clin. Pathol. 1989; 91: 265–270
- Geller R. B., Zahurak M., Hurwitz C. A., Burke J. P., Karp J. E., Piantadosi S., Civin C. I. Prognostic importance of immunophenotyping in adults with acute myeloblastic leukemia. The significance of the stem cell glycoprotein CD34 (MY10). Br. J. Haematol. 1990; 76: 340–347
- Sperling C., BÜChner T., Creutzig U., Ritter J., Harbott J., Fonatsch C., Sauerland C., Mielcarek M., Maschmeyer G., Loffler H., Ludwig W. Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood adult de novo AML. Leuk. Lymphoma 1995; 17: 417–426